{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UA-BP-GGP-00072",
      "entity_text" : "JAK",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:O60674",
      "entity_text" : "janus kinase 2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In PCV, greater than 90% of patients have the acquired janus kinase 2 (JAK2) V617F mutation 8, 9, causing activation of the intrinsic JAK / STAT (signal transducers and activators of transcription) pathway 8, 9.",
  "reading_complete" : "2020-08-02T11:49:18Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T11:48:18Z",
  "trigger" : "causing",
  "evidence" : [ "janus kinase 2 (JAK2) V617F mutation 8, 9, causing activation of the intrinsic JAK" ],
  "pmc_id" : "5582235",
  "score" : 0
}